shareholdersunite.com

The company has two divisions and five different businesses. All five are doing well at the moment with their photonics business as the standout. Two of their thin film businesses are in the very early innings, but they could get the ball running next year in either of these. The two established thin film businesses […]

[Read more →]

When market leaders in growth industries sell off, it opens opportunities for investors. The company really dominates its industry, and the growth slowdown looks temporary. Fundamentally, lower prices and medical research open up new markets and use cases, and that should benefit the company. Earnings growth should be a little faster than revenue growth due […]

[Read more →]

While shares sold off after earnings, we think investors are missing the 91% gross margins and free cash flow which reached a full half of the company’s revenues. The disappointment seems to be the result of the lack of announcement of new carriers, but the CC isn’t the place to do that anyway. We remain […]

[Read more →]

The shares of BioLife have sold off last month, and those of competitor CryoPort much more, closing what we thought was an irrational valuation gap. Critics argue that this is a commodity business but we see little or no signs of that. The big money is in their clients reaching commercial production after FDA approval, […]

[Read more →]

Fastly is a leader in edge computing with plenty of road ahead, as this industry is still in the early innings. Growth is brisk, and with the IPO funds, the company can keep investing and innovating to keep it going. However, because of valuations and competition concerns, we can’t recommend a Buy here. Source: Fastly […]

[Read more →]

A sector-wide SaaS business software platform, sparked by concerns of slowing corporate IT spending, has taken the shares of Alteryx already 35% off their top. There is no reason the company will be affected all that much given the secular tailwinds provided by Big Data and the move to the cloud. While the shares are […]

[Read more →]

The company is undergoing a protracted reorientation towards higher-margin analytics, given the decline of its legacy business. There are no overwhelming signs that its analytics business is growing, but the company made useful acquisitions and introduced quite a few new products. The company has an abundance of cash and generates more, and given the fairly […]

[Read more →]

The company delivered another good quarter and has again raised the full-year outlook while the shares have now pulled back a bit. The shares remain fully valued though, but that doesn’t mean they don’t offer opportunities. The company is likely to keep growing at 10%-15%, with expanding margins, operational leverage and increasing cash flow opening […]

[Read more →]

Investors have celebrated the company’s promising Q2 results, most of it driven by their adoption of the off-price strategy. As the results of this strategy are positive, management is now going all in, converting all its stores to off-price stores. With the guided positive cash flow, bankruptcy risks would diminish considerably, but the company still […]

[Read more →]

The company’s radar technology is hitting a sweet spot, much of it as a result of rising demand due to the proliferating threat from drones. It is building a US production facility that should be ready by the end of the year. If growth continues at the same pace next year, there is still room […]

[Read more →]